# Filana Therapeutics, Inc.: Form 8-K/A, filed Aug 9, 2024

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 8-K/A
- Filed: 2024-08-09
- Accepted by EDGAR: Aug 9, 2024, 08:23 ET
- Period: 2024-08-08
- Accession: 0001437749-24-025654
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/sava20240809_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000143774924025654/sava20240809_8ka.htm

Filed Aug 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-025654. Last ingested by Listed: Nov 5, 2026, 16:57 ET. No prices; not investment advice.